Ticker Details
C4 Therapeutics, Inc.
IPO Date:	October 2, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$393.62M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 3.99%
Avg Daily Range (30 D):	$0.12 | 4.18%
Avg Daily Range (90 D):	$0.11 | 4.32%

Institutional Daily Volume
Avg Daily Volume:	1.52M
Avg Daily Volume (30 D):	2.7M
Avg Daily Volume (90 D):	2.45M

Trade Size
Avg Trade Size (Sh.):	154
Avg Trade Size (Sh.) (30 D):	190
Avg Trade Size (Sh.) (90 D):	196

Institutional Trades
Total Institutional Trades:	1,080
Avg Institutional Trade:	$1.94M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$1.69M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.18M
Avg Closing Trade (30 D):	$.65M
Avg Closing Trade (90 D):	$.74M
Avg Closing Volume:	188.76K

News

May 20, 2026 @ 11:00 AM C4 Therapeutics to Participate in Upcoming Confere... Source: Not Specified

Feb 4, 2026 @ 12:00 PM C4 Therapeutics to Participate in the Guggenheim E... Source: Na

Jan 14, 2026 @ 12:00 PM C4 Therapeutics Outlines Strategic Milestones to A... Source: C4 Therapeutics, Inc.

Nov 25, 2025 @ 12:00 PM C4 Therapeutics to Participate in the 8th Annual E... Source: C4 Therapeutics

Sep 15, 2025 @ 10:33 PM Why C4 Therapeutics Stock Crushed the Market on Mo... Source: Eric Volkman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.1	$-.2	$-.09
Diluted EPS	$-1.1	$-.2	$-.09
Revenue	$34.86M	$6.15M	$11.02M
Gross Profit
Net Income / Loss	$-103.8M	$-25.13M	$-20.49M
Operating Income / Loss	$-113.84M	$-27.79M	$-23.15M
Cost of Revenue
Net Cash Flow	$9.98M	$-13.33M	$15.79M
PE Ratio